Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis

Background & objectives: Allergic rhinitis (AR) is an inflammatory disease prevalent worldwide which can affect both olfaction and quality of life (QoL). The objective of the present study was to assess olfaction and QoL changes in patients with AR before and after medical therapy. Methods: Adul...

Full description

Bibliographic Details
Main Authors: Katti Blessi Sara, V Rupa, L Jeyaseelan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Medical Research
Subjects:
Online Access:http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2022;volume=155;issue=3;spage=373;epage=379;aulast=Sara
_version_ 1797995741816291328
author Katti Blessi Sara
V Rupa
L Jeyaseelan
author_facet Katti Blessi Sara
V Rupa
L Jeyaseelan
author_sort Katti Blessi Sara
collection DOAJ
description Background & objectives: Allergic rhinitis (AR) is an inflammatory disease prevalent worldwide which can affect both olfaction and quality of life (QoL). The objective of the present study was to assess olfaction and QoL changes in patients with AR before and after medical therapy. Methods: Adult participants (>18 yr) with AR were recruited for this study. These patients prospectively underwent olfaction testing using the modified Connecticut Chemosensory Clinical Research Centre Test and QoL assessment using Rhinoconjunctivitis QoL Questionnaire (RQLQ) before and after standard medical therapy with topical steroids and/antihistaminics. Results: Of the 150 patients recruited, 72 per cent had intermittent AR. The symptom of hyposmia was present in 34 patients (22.7%) and was more prevalent in patients with moderate-to-severe type of AR (P<0.001). However, olfaction testing revealed hyposmia/anosmia in 44 patients (29.3%). Mean composite olfaction scores were significantly higher in patients with mild AR compared to moderate/severe AR (P=0.026). The pre-therapy mean composite olfaction score in the 34 patients with olfaction disturbances was 3.1 standard deviation (±1.06 SD). Following therapy, the mean composite olfaction score rose to 4.3 (±1.34 SD) and this change was found to be significant (P<0.001). Mean pre-therapy RQLQ scores were 2.87 (0.06-5.33) overall. Significant improvement was also found in RQLQ scores following therapy (P<0.001). Mean RQLQ scores were significantly lower in those with moderate-to-severe AR (P<0.001) as well as those with intermittent AR (P=0.004). Nine patients had persistently high RQLQ scores after medical therapy. Interpretation & conclusions: Both olfaction and QoL showed significant improvement after medical therapy in Indian adults with AR. In those patients who do not improve, other causes must be sought for the persistent symptoms.
first_indexed 2024-04-11T10:06:28Z
format Article
id doaj.art-a140813bb1914af9a8e364a67ba54a27
institution Directory Open Access Journal
issn 0971-5916
language English
last_indexed 2024-04-11T10:06:28Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Medical Research
spelling doaj.art-a140813bb1914af9a8e364a67ba54a272022-12-22T04:30:14ZengWolters Kluwer Medknow PublicationsIndian Journal of Medical Research0971-59162022-01-01155337337910.4103/ijmr.IJMR_1517_19Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitisKatti Blessi SaraV RupaL JeyaseelanBackground & objectives: Allergic rhinitis (AR) is an inflammatory disease prevalent worldwide which can affect both olfaction and quality of life (QoL). The objective of the present study was to assess olfaction and QoL changes in patients with AR before and after medical therapy. Methods: Adult participants (>18 yr) with AR were recruited for this study. These patients prospectively underwent olfaction testing using the modified Connecticut Chemosensory Clinical Research Centre Test and QoL assessment using Rhinoconjunctivitis QoL Questionnaire (RQLQ) before and after standard medical therapy with topical steroids and/antihistaminics. Results: Of the 150 patients recruited, 72 per cent had intermittent AR. The symptom of hyposmia was present in 34 patients (22.7%) and was more prevalent in patients with moderate-to-severe type of AR (P<0.001). However, olfaction testing revealed hyposmia/anosmia in 44 patients (29.3%). Mean composite olfaction scores were significantly higher in patients with mild AR compared to moderate/severe AR (P=0.026). The pre-therapy mean composite olfaction score in the 34 patients with olfaction disturbances was 3.1 standard deviation (±1.06 SD). Following therapy, the mean composite olfaction score rose to 4.3 (±1.34 SD) and this change was found to be significant (P<0.001). Mean pre-therapy RQLQ scores were 2.87 (0.06-5.33) overall. Significant improvement was also found in RQLQ scores following therapy (P<0.001). Mean RQLQ scores were significantly lower in those with moderate-to-severe AR (P<0.001) as well as those with intermittent AR (P=0.004). Nine patients had persistently high RQLQ scores after medical therapy. Interpretation & conclusions: Both olfaction and QoL showed significant improvement after medical therapy in Indian adults with AR. In those patients who do not improve, other causes must be sought for the persistent symptoms.http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2022;volume=155;issue=3;spage=373;epage=379;aulast=Saraallergic rhinitis - hyposmia - quality of life
spellingShingle Katti Blessi Sara
V Rupa
L Jeyaseelan
Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis
Indian Journal of Medical Research
allergic rhinitis - hyposmia - quality of life
title Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis
title_full Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis
title_fullStr Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis
title_full_unstemmed Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis
title_short Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis
title_sort changes in olfaction quality of life following standard medical therapy in patients with intermittent persistent allergic rhinitis
topic allergic rhinitis - hyposmia - quality of life
url http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2022;volume=155;issue=3;spage=373;epage=379;aulast=Sara
work_keys_str_mv AT kattiblessisara changesinolfactionqualityoflifefollowingstandardmedicaltherapyinpatientswithintermittentpersistentallergicrhinitis
AT vrupa changesinolfactionqualityoflifefollowingstandardmedicaltherapyinpatientswithintermittentpersistentallergicrhinitis
AT ljeyaseelan changesinolfactionqualityoflifefollowingstandardmedicaltherapyinpatientswithintermittentpersistentallergicrhinitis